Qingshan Li

First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial

Lin Shen, Yanqiao Zhang, Ziyu Li et al. · Nature Medicine · 2025 · 59 citations

Esophageal Cancer, Gastrointestinal Oncology, Medicine +8

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study

Jin Li, Zhendong Chen, Yuxian Bai et al. · Nature Medicine · 2024 · 42 citations

Esophageal Cancer, Medicine, Pathology +7

Comparison of early complications between the use of a cannulated screw locking plate and multiple cancellous screws in the treatment of displaced intracapsular hip fractures in young adults: a randomized controlled clinical trial

Zhiqiang Wang, Yi Yin, Qingshan Li et al. · Journal of Orthopaedic Surgery and Research · 2018 · 36 citations · Full text

Skeletal Trauma, Hip Arthroplasty, Surgical Stabilization +10

High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial

Jing You, Shuchai Zhu, Jiancheng Li et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 35 citations · Full text

Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial

Yuankai Shi, Jian Fang, Ligang Xing et al. · Nature Medicine · 2025 · 21 citations